yes this will be nice catalyst confirming CDX-011 place in the late-stage portfolio. This coudl also occur any day now IMO based on conference call yesterday- every thing on to "make the timeline". Too much to love about Celldex to keep this from rallying into the end of 4Q. The list is as long as your arm of positves coming over next several years to worry about a brief pullback from multi-year highs. Buy more Celldex.